Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313892068> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4313892068 endingPage "37" @default.
- W4313892068 startingPage "27" @default.
- W4313892068 abstract "Background: Since 2021, transarterial chemoembolization of the hepatic arteries (TACE) has been included in the recommendations of professional communities for the treatment of metastases of neuroendocrine liver tumors (NEO). However, the heterogeneity of both this group of patients and types of chemoembolization with a limited range of cytostatics used in the treatment makes it difficult to analyze the data and introduce the method into the combination therapy regimens.
 Aim: to study the effectiveness of transarterial chemoembolization with irinotecan-loaded drug-saturable microspheres for the treatment of patients with neuroendocrine tumors with liver metastases.
 Methods: A retrospective, observational, uncontrolled study of 34 patients with liver metastases from neuroendocrine cancer who underwent 52 TACE with irinotecan-loaded drug-saturable microspheres. Group 1 consisted of 15 patients who already had liver metastases at the time of the primary focus detection, group 2 included 19 patients with liver metastases having appeared some time after the detection of the primary focus. To plan and evaluate the effectiveness of chemoembolization, computed tomography and magnetic resonance imaging were used every 1015 weeks during the systemic treatment. All the patients received systemic NEO therapy before and after the embolization.
 Results: An increase in the progression-free time from 101 [57; 120] and 145 [89; 263] days after chemotherapy up to 300 [134; 344] and 304 [240; 342] days after TACE in groups 1 and 2, respectively, with no difference between the groups (p=0.31 and p=0.57, respectively). We did not find a linear relationship between the doubling time of the tumor and the change in the volume of the tumor lesion (R2=0.1085 and R2=0.0265 in groups 1 and 2). When comparing the intragroup scores, there was a statistically significant difference (p=0.009, p=0.046) in the tumor volume reduction and progression-free time between the patients who underwent TACE immediately and those who underwent TACE after chemotherapy. The diagnostic and angiographic images of liver metastases varied within the same organ and depended on the size of metastases. There were no adverse events after TACE.
 Conclusions: TACE with irinotecan-loaded drug-saturable microspheres is an effective method for the treatment of liver metastases of neuroendocrine cancer, allowing one to increase the time without progression." @default.
- W4313892068 created "2023-01-10" @default.
- W4313892068 creator A5012248573 @default.
- W4313892068 creator A5056824676 @default.
- W4313892068 creator A5061447824 @default.
- W4313892068 creator A5062539620 @default.
- W4313892068 creator A5064115272 @default.
- W4313892068 creator A5088159165 @default.
- W4313892068 creator A5089287267 @default.
- W4313892068 creator A5089721188 @default.
- W4313892068 date "2023-01-24" @default.
- W4313892068 modified "2023-09-30" @default.
- W4313892068 title "Evaluation of the effectiveness of transarterial chemoembolization irinotecan-loaded with drug-saturable microspheres for the treatment of patients with neuroendocrine tumors with liver metastases" @default.
- W4313892068 cites W1979469384 @default.
- W4313892068 cites W1990509102 @default.
- W4313892068 cites W2006821285 @default.
- W4313892068 cites W2015149820 @default.
- W4313892068 cites W2100158834 @default.
- W4313892068 cites W2461450836 @default.
- W4313892068 cites W2592144107 @default.
- W4313892068 cites W2725873592 @default.
- W4313892068 cites W2893592585 @default.
- W4313892068 cites W3148676889 @default.
- W4313892068 cites W3208389663 @default.
- W4313892068 doi "https://doi.org/10.17816/clinpract115017" @default.
- W4313892068 hasPublicationYear "2023" @default.
- W4313892068 type Work @default.
- W4313892068 citedByCount "0" @default.
- W4313892068 crossrefType "journal-article" @default.
- W4313892068 hasAuthorship W4313892068A5012248573 @default.
- W4313892068 hasAuthorship W4313892068A5056824676 @default.
- W4313892068 hasAuthorship W4313892068A5061447824 @default.
- W4313892068 hasAuthorship W4313892068A5062539620 @default.
- W4313892068 hasAuthorship W4313892068A5064115272 @default.
- W4313892068 hasAuthorship W4313892068A5088159165 @default.
- W4313892068 hasAuthorship W4313892068A5089287267 @default.
- W4313892068 hasAuthorship W4313892068A5089721188 @default.
- W4313892068 hasBestOaLocation W43138920681 @default.
- W4313892068 hasConcept C121608353 @default.
- W4313892068 hasConcept C126322002 @default.
- W4313892068 hasConcept C126838900 @default.
- W4313892068 hasConcept C127413603 @default.
- W4313892068 hasConcept C143409427 @default.
- W4313892068 hasConcept C167135981 @default.
- W4313892068 hasConcept C189942447 @default.
- W4313892068 hasConcept C2776035437 @default.
- W4313892068 hasConcept C2776694085 @default.
- W4313892068 hasConcept C2779066768 @default.
- W4313892068 hasConcept C2780259306 @default.
- W4313892068 hasConcept C42360764 @default.
- W4313892068 hasConcept C526805850 @default.
- W4313892068 hasConcept C71924100 @default.
- W4313892068 hasConcept C90924648 @default.
- W4313892068 hasConceptScore W4313892068C121608353 @default.
- W4313892068 hasConceptScore W4313892068C126322002 @default.
- W4313892068 hasConceptScore W4313892068C126838900 @default.
- W4313892068 hasConceptScore W4313892068C127413603 @default.
- W4313892068 hasConceptScore W4313892068C143409427 @default.
- W4313892068 hasConceptScore W4313892068C167135981 @default.
- W4313892068 hasConceptScore W4313892068C189942447 @default.
- W4313892068 hasConceptScore W4313892068C2776035437 @default.
- W4313892068 hasConceptScore W4313892068C2776694085 @default.
- W4313892068 hasConceptScore W4313892068C2779066768 @default.
- W4313892068 hasConceptScore W4313892068C2780259306 @default.
- W4313892068 hasConceptScore W4313892068C42360764 @default.
- W4313892068 hasConceptScore W4313892068C526805850 @default.
- W4313892068 hasConceptScore W4313892068C71924100 @default.
- W4313892068 hasConceptScore W4313892068C90924648 @default.
- W4313892068 hasIssue "4" @default.
- W4313892068 hasLocation W43138920681 @default.
- W4313892068 hasOpenAccess W4313892068 @default.
- W4313892068 hasPrimaryLocation W43138920681 @default.
- W4313892068 hasRelatedWork W1503298002 @default.
- W4313892068 hasRelatedWork W2073570175 @default.
- W4313892068 hasRelatedWork W2077760523 @default.
- W4313892068 hasRelatedWork W2094727229 @default.
- W4313892068 hasRelatedWork W2353647715 @default.
- W4313892068 hasRelatedWork W2390482019 @default.
- W4313892068 hasRelatedWork W3013145321 @default.
- W4313892068 hasRelatedWork W3210359220 @default.
- W4313892068 hasRelatedWork W4243702326 @default.
- W4313892068 hasRelatedWork W959313947 @default.
- W4313892068 hasVolume "13" @default.
- W4313892068 isParatext "false" @default.
- W4313892068 isRetracted "false" @default.
- W4313892068 workType "article" @default.